Aspirin Prescription and Outcomes in Hemodialysis Patients

American Journal of Kidney Diseases

Volumn 51, Issue 6, 2008, Pages 1070-1071

  Tseng, Guan Ying ^a   Lin, Hwai Jeng ^b  

^a Ton Yen General Hospital   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

CHRONIC KIDNEY FAILURE; HEART INFARCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; KIDNEY FUNCTION; LETTER; OUTCOME ASSESSMENT; PEPTIC ULCER; PRESCRIPTION; PROSPECTIVE STUDY; RISK; STROKE; UREMIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; GASTROINTESTINAL HEMORRHAGE; HUMANS; PEPTIC ULCER; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 43849086625     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.01.035     Document Type: Letter

References (6)

1. Ethier J., Bragg-Gresham J.L., Piera L., et al. Aspirin prescription and outcomes in hemodialysis patients: the dialysis outcomes and practice pattern study (DOPPS). Am J Kidney Dis 50 (2007) 602-611
2. Ridker P.M., Cook N.R., Lee I.M., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 (2005) 1293-1304
3. Sorensen H.T., Mellemkjaer L., Blot W.J., et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 95 (2000) 2218-2224
4. Lanas A., Bajador E., Serrano P., et al. Nitrovasculators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 343 (2000) 834-839
5. Nardone G., Rocco A., and Fiorillo M. Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure. Helicobacter 10 (2005) 53-58
6. Tseng G.Y., Lin H.J., Fang C.T., et al. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther 26 (2007) 925-933